Personalis Inc (PSNL) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $9.03
• Market Cap: $737.96M
• EPS: $-0.83
• 52-Week High: $11.50
• 52-Week Low: $2.83

Market Sentiment

Personalis Inc currently has a Neutral sentiment score of 0.11.

About Personalis Inc

Personalis, Inc. is a pioneering leader in the cancer genomics field, offering advanced genomic sequencing and analysis that empowers personalized cancer therapies. Based in Menlo Park, California, the company utilizes its proprietary technology platform to generate high-quality genomic data, enhancing precision medicine initiatives and supporting healthcare professionals in making informed treatment decisions. With a robust and expanding portfolio of innovative solutions, Personalis is strat...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Personalis Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does PSNL pay dividends?

Personalis Inc (PSNL) does not currently pay a regular dividend.

What is PSNL's market cap?

Personalis Inc (PSNL) has a market capitalization of $737.96M with a current stock price of $9.03.